Literature DB >> 2914259

Efficacy of empirical cardiac pacing in syncope of unknown cause.

M F Rattes1, G J Klein, A D Sharma, J A Boone, C Kerr, S Milstein.   

Abstract

Cardiac pacing is often considered in patients with recurrent syncope after repeated attempts to document the cause have failed. To assess the results of this tactic we reviewed the records of 104 patients who had received pacemakers for known or suspected bradycardia between September 1973 and March 1985. The patients were classified retrospectively into three groups: group 1 (31 patients with a mean age of 73 years) had unequivocal documentation of bradycardia during syncope, group 2 (42 patients with a mean age of 71 years) had electrocardiographic or electrophysiologic evidence of potential bradycardia but no documentation during spontaneous syncope, and group 3 (31 patients with a mean age of 69 years) had a history "suggestive of" bradycardia-related syncope but no other evidence to support the diagnosis. The rates of recurrence of syncope during follow-up were 6.3%, 7.3% and 32.2% in groups 1, 2 and 3 respectively (p less than 0.01). In group 3 recurrence was more probable in patients with loss of consciousness for more than 2 minutes than in those who were unconscious for 2 minutes or less (p less than 0.05). The results suggest that pacemaker implantation is justified for recurrent syncope after extensive attempts to document a spell have failed if abnormal diagnostic test results suggest bradycardia as a possible cause. Empirical pacing is less satisfactory in patients with normal results of evaluation but may arguably be justified when patients have recurrent syncope with injury.

Entities:  

Mesh:

Year:  1989        PMID: 2914259      PMCID: PMC1268660     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  13 in total

1.  OLD PEOPLE AT HOME. THEIR UNREPORTED NEEDS.

Authors:  J WILLIAMSON; I H STOKOE; S GRAY; M FISHER; A SMITH; A MCGHEE; E STEPHENSON
Journal:  Lancet       Date:  1964-05-23       Impact factor: 79.321

2.  Syncope. Physiological considerations and an analysis of the clinical characteristics in 510 patients.

Authors:  H H WAYNE
Journal:  Am J Med       Date:  1961-03       Impact factor: 4.965

3.  Issues in evaluating patients with syncope.

Authors:  W Kapoor; M Karpf; G S Levey
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

4.  Intractable syncope.

Authors:  H A Kontos
Journal:  Hosp Pract (Off Ed)       Date:  1981-07

5.  Repeated syncope with negative diagnostic evaluation. To pace or not to pace?

Authors:  C K Kwoh; J R Beck; S G Pauker
Journal:  Med Decis Making       Date:  1984       Impact factor: 2.583

6.  Intracardiac electrophysiologic techniques in recurrent syncope of unknown case.

Authors:  J P DiMarco; H Garan; J W Harthorne; J N Ruskin
Journal:  Ann Intern Med       Date:  1981-11       Impact factor: 25.391

7.  Carotid sinus hypersensitivity and syncope.

Authors:  P F Walter; I S Crawley; E R Dorney
Journal:  Am J Cardiol       Date:  1978-09       Impact factor: 2.778

8.  Evaluation and outcome of emergency room patients with transient loss of consciousness.

Authors:  S C Day; E F Cook; H Funkenstein; L Goldman
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

9.  A prospective evaluation and follow-up of patients with syncope.

Authors:  W N Kapoor; M Karpf; S Wieand; J R Peterson; G S Levey
Journal:  N Engl J Med       Date:  1983-07-28       Impact factor: 91.245

10.  Syncope of unknown origin. The need for a more cost-effective approach to its diagnosis evaluation.

Authors:  W N Kapoor; M Karpf; Y Maher; R A Miller; G S Levey
Journal:  JAMA       Date:  1982-05-21       Impact factor: 56.272

View more
  1 in total

1.  Syncope and bifascicular block in the absence of structural heart disease.

Authors:  Ricardo Rivera-López; Mercedes Cabrera-Ramos; Laura Jordán-Martinez; Juan Jimenez-Jaimez; Rosa Macias-Ruiz; Eduardo Aguilar-Alonso; Ricardo Rivera-Fernandez; Emilio Sanchez-Cantalejo; Luis Tercedor; Miguel Alvarez
Journal:  Sci Rep       Date:  2020-05-18       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.